Table 5 Changes in Clinical and PKG measures following treatment for bradykinesia or dyskinesia
a PwP treated for bradykinesia bradykinesia score ≥ 23 N = 57 | |||||
|---|---|---|---|---|---|
Mean (Std) | Δ% | ES | p value | ||
Hohn &Yahr | 2.4 (1) | n/a | n/a | n/a | |
Years of PD | 5.7 (3.8) | n/a | n/a | ||
PDQ39 | Before | 29.8 (19.4) | |||
After | 25.6 (19.1) | 14.1% | 0.22 | 0.26 | |
UPDRS III | Before | 38 (10.2) | |||
After | 32.7 (10.9) | 13.9% | 0.49 | 0.008 | |
UPDRS Total | Before | 65.8 (18.4) | |||
After | 55.7 (20.5) | 15.4% | 0.49 | 0.003 | |
Median BKS | Before | 29.4 (4.2) | |||
After | 27 (4.3) | 8.2% | 0.59 | 0.002 | |
PTB | Before | 63 (22) | |||
After | 50 (24) | 20.6% | 0.56 | 0.004 | |
b PwP treated for dyskinesia PTD ≥ 20% N = 27 | |||||
|---|---|---|---|---|---|
Mean (Std) | Δ% | ES | p value | ||
Hohn &Yahr | 2.4 (0.7) | n/a | n/a | n/a | |
Years of PD | 9.4 (5.8) | n/a | n/a | n/a | |
UPDRS IV | Before | 7.7 (4) | |||
After | 4.3 (4.3) | 44.2% | 0.79 | 0.0009 | |
UPDRS Total | Before | 58 (18) | |||
After | 45 (23) | 22.4% | 0.57 | 0.010 | |
PTD | Before | 42 (20) | |||
After | 23 (16) | 45.2% | 1.19 | 0.0007 | |
Median DKS | Before | 14 (13) | |||
After | 6.2 (4.3) | 54.9% | 1.81 | 0.0006 | |